• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Abbott

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

by Jasmine Pennic 04/30/2025 Leave a Comment

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

What You Should Know:  - Abbott, a provider of continuous glucose monitoring (CGM) biowearable technology, has announced a landmark agreement with Epic Systems, a major provider of electronic health records (EHR).  - The first-of-its-kind collaboration for Abbott will integrate patient glucose data from its leading FreeStyle Libre CGM systems directly into Epic's EHR platform across the United States. FreeStyle Libre Integration with Epic Aura The integration leverages
Read More

Glooko Integrates Abbott FreeStyle Libre CGM, Enhancing Diabetes Management

by Jasmine Pennic 03/24/2025 Leave a Comment

Abbott Unveils FreeStyle Libre 3 Plus: World's Smallest CGM Sensor with Future AID Compatibility

What You Should Know:  - Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform's capabilities with the integration of Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) systems in the United States.  - The newly implemented integration allows individuals with diabetes to seamlessly synchronize data from their FreeStyle Libre CGM systems with other vital health metrics, including insulin
Read More

Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland

by Jasmine Pennic 11/18/2024 Leave a Comment

Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland

What You Should Know:  - Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.  - Abbott's FreeStyle Libre portfolio is the world's leading continuous glucose monitoring system, helping more than 6 million people with diabetes across over 60 countries.  Boosting Irish Economy and Manufacturing Capabilities The Kilkenny facility is part of a €440 million
Read More

Abbott’s FreeStyle Libre CGM Systems Now Cleared for Use During Imaging Procedures

by Jasmine Pennic 10/30/2024 Leave a Comment

Abbott's FreeStyle Libre CGM Systems Now Cleared for Use During Imaging Procedures

What You Should Know:  - Abbott  announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.  - The development makes Abbott's systems the first and only patient-applied CGM sensors approved for use during these screenings, offering greater convenience and potential cost savings for people with diabetes. Improving Diabetes
Read More

Abbott Launches OTC Continuous Glucose Monitor, Lingo

by Jasmine Pennic 09/05/2024 Leave a Comment

Abbott Launches OTC Continuous Glucose Monitor, Lingo

What You Should Know:  - Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness.  - Lingo is the first CGM available without a prescription designed for individuals who want to improve their overall health and wellness, regardless of whether they have diabetes. A Powerful Tool for Health Management Lingo combines a biosensor
Read More

Abbott and Medtronic Partner to Integrate CGM System & Insulin Delivery Devices

by Jasmine Pennic 08/07/2024 Leave a Comment

Abbott and Medtronic Partner to Integrate CGM System & Insulin Delivery Devices

What You Should Know:  - Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems.  - The strategic collaboration aims to improve diabetes management by enabling more precise insulin dosing and reducing the burden on patients. CGM System and Insulin Delivery Devices Integration The new CGM sensor,
Read More

Abbott Receives FDA Approval for World’s First Dual Chamber Leadless Pacemaker

by Jasmine Pennic 07/05/2023 Leave a Comment

Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker

What You Should Know:  The U.S. Food and Drug Administration (FDA) approves Abbott’s AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.Abbott’s breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA batteryLeadless pacemakers provide a new minimally invasive option
Read More

Key Challenges and Solutions to Enhance the Post-Procedure Experience

by Syed Hamza Sohail 03/24/2023 Leave a Comment

KEY CHALLENGES AND SOLUTIONS TO ENHANCE THE POST-PROCEDURE EXPERIENCE

What You Should Know: - Abbott today released the latest installment in the company’s multi-year Beyond Intervention series of global healthcare market research designed to uncover challenges that arise within the patient journey of people living with cardiovascular disease and to identify opportunities for patient care improvement. - The latest report stems from a survey of more than 2,000 patients, physicians and healthcare leaders, and reveals
Read More

The Quickening Pulse of the Ambulatory Diagnostic Cardiology Market

by Kelly Patrick, Principal Analyst at Signify Research 02/14/2023 Leave a Comment

Quickening Pulse of the Ambulatory Diagnostic Cardiology Market

The Global Ambulatory Diagnostic Cardiology Market is evolving at a rapid pace, driven by technological developments, and shifting models of healthcare service delivery and funding. The overall market will grow from $2.5 billion in 2021, to $3.3 billion by 2026, with Long-Term ECG and, to a lesser extent, Mobile Cardiac Telemetry (MCT), being the principal engines of growth. Unsurprisingly, these two markets are garnering serious attention from large incumbent vendors in the more established
Read More

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

by Fred Pennic 12/20/2022 Leave a Comment

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |